Himani Goyal, MD, assesses the benefits of proactive glaucoma management through interventional procedures beyond traditional treatments, focusing on treatment customization based on factors such as visual potential, glaucoma staging, IOP targets, comorbid conditions, and patient preferences.
Lana Rifkin, MD, a uveitis specialist at Ophthalmic Consultants of Boston, shared insights into her work and her role as committee chair of the uveitis section for the upcoming EnVision Summit, which will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.
According to Robert Latkany, MD, understanding the causes and recognizing these diagnostic features are essential for effective treatment.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
Deepinder Dhaliwal, MD, LAc, discusses longterm outcomes of Descemet Stripping Only (DSO) for Fuchs dystrophy at NYU's Journal Club, highlighting a 77% success rate at 5 years and evolving techniques.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
At the FLORetina Conference in Florence, Italy, John W. Kitchens, of Retina Associates of Kentucky, highlighted strategies to enhance efficiency in retina practices, addressing challenges like staff shortages and rising patient volumes. He emphasized streamlined workflows, advanced diagnostic tools, and enhanced patient communication to optimize care and improve outcomes.
In an interview with Ophthalmology Times, clinical trial investigator Zaina Al-Mohtaseb MD, noted the CLARA Phase 1/2 trial demonstrated the safety, efficacy, and simplicity of corneal endothelial cell injection therapy with a rho kinase inhibitor, offering a less invasive alternative to traditional corneal transplantation for treating corneal edema.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
Researchers at the USC Ginsburg Institute for Biomedical Therapeutics and the USC Roski Eye Institute are advancing a new treatment for dry age-related macular degeneration, a leading cause of blindness in older adults.
This Week in Ophthalmology is a weekly video series highlighting some of the top articles and videos featured on the Ophthalmology Times website.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under clinical trial is pacibekitumab, an IL-6 ligand-blocking antibody.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
Ahead of this year's Floretina meeting and International Congress on OCT Angiography, En Face OCT and Advances in OCT (ICOOR), David Hutton of Ophthalmology Times spoke with Charles Wykoff, MD, PhD. At FLORetina ICOOR, he presented on a number of topics, including diabetic retinopathy—the subject of his conversation with the Eye Care Network.
This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
In this final case, Sumit Sharma, MD, FASRS presents his case of neovascular AMD with a severe retinal pigment epithelial detachment who experienced a higher durability with a newer agent.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.
Welcome to the latest edition of This Week in Ophthalmology, a video series highlighting some of the top articles featured on the Ophthalmology Times website.
Lisa J. Faia, MD asks the panel about their concerns regarding the safety of newer agents for the broad array of retinal vascular diseases, highlighting the similarities and differences between clinical trial outcomes and real-world results.
